**Texas Files Lawsuit Against Johnson & Johnson and Kenvue Over Tylenol** Texas Attorney General Ken Paxton has filed a lawsuit against Johnson & Johnson and its spin-off Kenvue, alleging that the companies concealed risks associated with Tylenol, particularly its potential links to autism and attention deficit hyperactivity disorder when taken during pregnancy. The lawsuit, submitted in state court on Tuesday, claims that the drugmakers engaged in deceptive marketing practices despite being aware of the risks. This legal action follows recent comments from former President Donald Trump, who suggested that Tylenol could cause autism in children, a claim that lacks scientific backing. "Big Pharma betrayed America by profiting off of pain and pushing pills regardless of the risks," Paxton stated. He accused the companies of lying for decades and endangering millions for profit. The lawsuit adds to the scrutiny faced by the companies, which has been a focal point for various health advocates, including Robert F. Kennedy Jr., the Secretary of Health and Human Services. Trump has intensified his criticism of Tylenol, advising parents on social media to avoid giving the medication to children without scientific justification. Kenvue, which has been manufacturing Tylenol since its spin-off in 2023, has called the allegations unfounded. The company emphasized that both pain and fever in pregnant women can pose risks to their children. "We are deeply concerned by the perpetuation of misinformation on the safety of acetaminophen and the potential impact that could have on the health of American women and children," Kenvue stated. The lawsuit claims that both companies failed to disclose evidence linking acetaminophen, the active ingredient in Tylenol, to neurodevelopmental disorders when used by pregnant women. Johnson & Johnson, which divested its consumer health business, stated that Kenvue is responsible for all rights and liabilities related to Tylenol. Paxton criticized the motives behind the spin-off, suggesting that Johnson & Johnson was attempting to evade responsibility by transferring liability to Kenvue. In the lawsuit, Paxton argues that other FDA-regulated drugs provide detailed risk information on their labels, even when the science is not fully settled. He seeks a court order to prevent the companies from engaging in deceptive advertising practices regarding Tylenol and demands the destruction of any marketing materials that claim the drug is safe for pregnant women. The lawsuit also seeks civil penalties against the companies. Paxton, who has served as Texas Attorney General since 2015, is known for his conservative legal pursuits. He is currently running for a U.S. Senate seat in Texas. The controversy surrounding Tylenol has raised concerns among medical professionals. The American College of Obstetricians and Gynecologists has labeled Trump's statements as "irresponsible" and continues to recommend Tylenol for pain relief during pregnancy. Earlier this month, Kenvue defended Tylenol's safety in response to a citizen petition requesting label changes. The company stated that the proposed changes are not supported by scientific evidence and are legally improper. Kenvue reiterated that the "overwhelming weight of the evidence" does not support claims that acetaminophen poses a risk for neurodevelopmental disorders.